ArticleCureus2025
Clinical Implications of Metachronous Testicular Tumours.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Testicular tumours are the most common solid malignancy in young males. Usually being unilateral and of germ cell tumour type, bilateral testicular tumours are very rare. The postoperative follow-up with imaging studies is of high importance, in order to rule out recurrence or the development of new testicular tumours. We present the case of a 53-year-old man with a history of left radical orchiectomy and testicular prosthesis placement performed 29 years ago, for testicular teratocarcinoma stage I, who underwent an MRI for the evaluation of a symptomatic anal fistula. MRI of the fistula showed a solid mass in his right testis suggestive of seminoma. The patient had undergone a right radical orchiectomy with an anatomopathological result of seminoma pT1a. CT of the thorax, abdomen, and pelvis and preoperative serum tumour markers were normal. At the four-week postoperative follow-up, the patient reported hot flashes, and his wound showed good appearance. Exogenous testosterone was prescribed, and the patient was referred to an oncologist who decided no adjuvant treatment was necessary. At the one-year follow-up, the patient was asymptomatic. Control CT and serum tumour markers were within normal limits. Long-term follow-up is necessary in patients with a previous history of testicular tumour, using imaging studies to detect recurrence or a new testicular tumour. Testis-sparing surgery should be considered as the first option when tumours are less than 2 cm. Patients with bilateral orchiectomy should start exogenous testosterone as soon as possible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.